Abstract
Coronavirus disease 2019 (COVID-19), confirmed as the global pandemic on March 11, 2020, by the World Health Organization (WHO), was caused by the outbreak of an emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first reported in Wuhan city, China, in December 2019. Based on the previous pandemic, such as severe acute respiratory syndrome (SARS) from 2002 to 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. The scientific developments have fast-tracked our insights SARS-CoV-2 epidemiology, likewise vaccinology relevant for developing drugs for viral infections treatment. As there are not many detailed interventions and vaccines available for disease control, the pandemic COVID-19 poses countless threats to global public health, causing a great level of insecurity and unrest worldwide. To provide an inclusive overview to global health authorities and prospective readers worldwide, we detailed in this review the epidemiology and vaccinology of SARS-CoV-2 in Nigeria.
Highlights
J TMGH International Journal of Travel Medicine and Global HealthSevere Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Epidemiology and Vaccinology in Nigeria
In the 1960s, human coronaviruses were discovered and found responsible for most respiratory or gastrointestinal diseases in the human population
When a study was done on the early transmission dynamics of the novel Coronavirus, it was reported that the majority of affected patients were males.[30]
Summary
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Epidemiology and Vaccinology in Nigeria. Ridwan Olamilekan Adesola1* ID , Oluwatobi Emmanuel Oladele[2] ID , Ahmed Oluwasegun Tajudeen[3] ID , Ogundepo Oluwatobi Moses[2] ID , Murali Dinesh[4] ID
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Travel Medicine and Global Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.